Funding in, findings out

For any dataset: the NCI award that paid to create it, and the awards that got a published finding out of it afterwards.

Pick a dataset

332 of 602 datasets have at least one award resolved. 31 have awards on both sides.

Datasets with awards on both sides - awards that paid to create it awards that funded work using it

TCGA-THYM 17 → 22 ORGANOID-PANCREATIC 13 → 49 CPTAC-3 10 → 36 WCDT-MCRPC 9 → 43 TCGA-STAD 18 → 10 BEATAML1.0-COHORT 7 → 33

TARGET-OS

Osteosarcoma

2 awards paid to create it · 20 awards funded work that used it

Awards that paid to create this data (2)

Credited on the dataset's own marker paper

The dataset

Articles that used it (5)

The accession appears in their methods section

Awards those articles were funded by (6 of 20)

NCI money spent on data it did not pay to generate

TARGET-OSOsteosarcomaGDC

The best connected are shown.

Direct evidence: the award is on the paper, or the accession is in the articleWeaker: infrastructure support, or use declared but not shownHover any card to follow its chain

Awards that paid to create this data

Credited on the dataset's own marker paper.

Award	Project	Evidence
P30CA021765 P30FY1985–2026$336.2M	Cancer Biology (CBP) Douglas R. Green, Elizabeth Fox · ST. JUDE CHILDREN'S RESEARCH HOSPITAL	API2
R01CA168875 R01FY2012–2016$1.8M	Molecular Targeted Therapy for Retinoblastoma Michael A Dyer · ST. JUDE CHILDREN'S RESEARCH HOSPITAL	API

Awards that funded work using this data

5 of 10 traced articles report an NCI award. 1 of these awards also paid to create the data - the same team publishing again on its own cohort, not a duplicated row.

Award	Project	Articles it is credited on	Evidence
P30CA021765 P30FY1985–2026$336.2M	Cancer Biology (CBP) Douglas R. Green, Elizabeth Fox · ST. JUDE CHILDREN'S RESEARCH HOSPITAL	Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tum… 2018	API2
U10CA098543 U10FY2003–2013$335.5M	Children's Oncology Group Chair's Grant PETER C. ADAMSON, GREGORY H REAMAN · CHILDREN'S HOSP OF PHILADELPHIA	Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tum… 2018	API
F30CA271797 F30FY2022–2025$155k	Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T Cells Tara Murty · STANFORD UNIVERSITY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
K08CA267057 K08FY2022–2026$1.1M	Defining Pre-treatment Correlates of Patient GD2 CAR T Cell Exhaustion and Memory Using Multi-Dimensional Immune Profiling Sneha Ramakrishna · STANFORD UNIVERSITY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
P30CA124435 P30FY2007–2026$125.5M	Biostatistics MANISHA DESAI, Ryan D. Leib · STANFORD UNIVERSITY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
R01CA202987 R01FY2016–2020$2.2M	Functions of Nonclassical Monocytes in the Vasculature Catherine C Hedrick · LA JOLLA INSTITUTE FOR IMMUNOLOGY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
U01CA224766 U01FY2018–2021$1.4M	Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers Catherine C Hedrick, Rosandra Natasha Kaplan · LA JOLLA INSTITUTE FOR IMMUNOLOGY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
U24CA224309 U24FY2017–2026$19.9M	Stanford Cancer Immune Monitoring and Analysis Center (CIMAC) Sean Curtis Bendall, Holden T. Maecker · STANFORD UNIVERSITY	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
U24CA224316 U24FY2017–2022$6.8M	Cancer Immunologic Data Commons (CIDC) Supplement Request Ethan Cerami, Franziska Michor · DANA-FARBER CANCER INST	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
U24CA224331 U24FY2017–2026$18.4M	Cancer Immune Monitoring and Analysis Center FRANK S HODI, Catherine Ju-Ying Wu · DANA-FARBER CANCER INST	Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T c… 2024	API
P30CA008748 P30FY1985–2026$717.9M	Antitumor Assessment Elisa de Stanchina, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. 2021	API
P50CA217694 P50FY2018–2025$33.2M	Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma Marc Ladanyi, SAMUEL SINGER · SLOAN-KETTERING INST CAN RESEARCH	Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. 2021	API
K08CA273527 K08FY2022–2026$1.3M	Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis Anne Van Arsdale · ALBERT EINSTEIN COLLEGE OF MEDICINE	Targeted in silico characterization of fusion transcripts in tumor and normal tissues via… 2023	API
R50CA211461 R50FY2016–2020$1.7M	Open Software and Resource Development Leveraging Next-gen Sequencing Data to Facilitate Computational Analysis of Cancer Biology Brian Haas · BROAD INSTITUTE, INC.	Targeted in silico characterization of fusion transcripts in tumor and normal tissues via… 2023	API
U24CA180922 U24FY2013–2022$7.5M	Trinity: Transcriptome assembly for genetic and functional analysis of cancer Brian Haas, Eric Banks · BROAD INSTITUTE, INC.	Targeted in silico characterization of fusion transcripts in tumor and normal tissues via… 2023	API
U24CA258406 U24FY2021–2025$4.4M	The Integrative Genomics Viewer (IGV) for Cancer Research JILL P. MESIROV, James Thomas Robinson · UNIVERSITY OF CALIFORNIA, SAN DIEGO	Targeted in silico characterization of fusion transcripts in tumor and normal tissues via… 2023	API
P30CA125123 P30FY2007–2026$131.6M	Patient-Derived Xenograft Shared Resource Michael T. Lewis, Carlos Almeida Ramos · BAYLOR COLLEGE OF MEDICINE	MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophage… 2023	API
R01CA215452 R01FY2017–2021$2.0M	Identifying and targeting oncogenic Myc enhancer control in pediatric tumors Thomas Westbrook, Charles Yang Lin · BAYLOR COLLEGE OF MEDICINE	MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophage… 2023	API
R01CA229510 R01FY2019–2023$2.8M	Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy Christiane Querfeld · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE	MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophage… 2023	API
R21CA267914 R21FY2022–2023$430k	DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMA Jennifer J Kohler, Jason Yustein · EMORY UNIVERSITY	MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophage… 2023	API

Awards that maintain or redistribute this data

Resource and center grants credited on articles that used the data. Kept out of the flow above because they pay for the pipes, not for a cohort or a finding.

Award	Project	Evidence
P30CA008748 P30FY1985–2026$717.9M	Antitumor Assessment Elisa de Stanchina, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	API
P30CA124435 P30FY2007–2026$125.5M	Biostatistics MANISHA DESAI, Ryan D. Leib · STANFORD UNIVERSITY	API
P30CA125123 P30FY2007–2026$131.6M	Patient-Derived Xenograft Shared Resource Michael T. Lewis, Carlos Almeida Ramos · BAYLOR COLLEGE OF MEDICINE	API
P50CA217694 P50FY2018–2025$33.2M	Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma Marc Ladanyi, SAMUEL SINGER · SLOAN-KETTERING INST CAN RESEARCH	API
U01CA224766 U01FY2018–2021$1.4M	Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers Catherine C Hedrick, Rosandra Natasha Kaplan · LA JOLLA INSTITUTE FOR IMMUNOLOGY	API
U10CA098543 U10FY2003–2013$335.5M	Children's Oncology Group Chair's Grant PETER C. ADAMSON, GREGORY H REAMAN · CHILDREN'S HOSP OF PHILADELPHIA	API
U24CA180922 U24FY2013–2022$7.5M	Trinity: Transcriptome assembly for genetic and functional analysis of cancer Brian Haas, Eric Banks · BROAD INSTITUTE, INC.	API
U24CA224309 U24FY2017–2026$19.9M	Stanford Cancer Immune Monitoring and Analysis Center (CIMAC) Sean Curtis Bendall, Holden T. Maecker · STANFORD UNIVERSITY	API
U24CA224316 U24FY2017–2022$6.8M	Cancer Immunologic Data Commons (CIDC) Supplement Request Ethan Cerami, Franziska Michor · DANA-FARBER CANCER INST	API
U24CA224331 U24FY2017–2026$18.4M	Cancer Immune Monitoring and Analysis Center FRANK S HODI, Catherine Ju-Ying Wu · DANA-FARBER CANCER INST	API
U24CA258406 U24FY2021–2025$4.4M	The Integrative Genomics Viewer (IGV) for Cancer Research JILL P. MESIROV, James Thomas Robinson · UNIVERSITY OF CALIFORNIA, SAN DIEGO	API

Where the links come from

NIH RePORTER maps a PMID to the awards that reported it. On a dataset’s marker paper that gives the awards which created it; on an article that used the data, the awards which funded that use.

The two sides are not measured alike. Generation is complete: a dataset has one marker paper and every award on it is resolved. Reuse is a sample - the articles using a dataset can number in the thousands, and only the few dozen strongest are retrieved and looked up. Every award shown here funded reuse; there are more that are not shown.

How far it reaches

283 datasets have an award credited with creating them, 80 with using them, and 31 both.

What is missing

No citable accession means no traceable articles; no authoritative marker paper means no attributable generation award. Absence is a gap in the record. Methods.

Start from an award instead, and see every dataset it touches.